Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Haemophilus influenzae B Ab:MCnc:Pt:Ser:Qn

Known as: Haemophilus influenzae B Ab:KütlKons:Zml?:Ser:Kant, Haem influ B Ac Ser-mCnc, Haem influ B Ab Ser-mCnc 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
The epidemiology of invasive Haemophilus influenzae infections was evaluated in Ontario between 1989 and 2007 to assess the… Expand
2009
2009
OBJECTIVE. New vaccines that offer protection against otitis media caused by nontypeable Haemophilus influenzae and by Moraxella… Expand
2005
2005
BACKGROUND The generalization of the vaccination against H. influenzae b (Hib), according to its integration in the French… Expand
Highly Cited
1993
Highly Cited
1993
For a seven year period (1985-91) clinical and epidemiological data were prospectively collected on children aged < 10 years with… Expand
1991
1991
OBJECTIVE To evaluate the immunologic potential of infants 7 to 15 months of age to respond to Haemophilus influenzae type b… Expand
1987
1987
Induction of surface Mac-1 by inflammatory stimuli is fundamental to a broad spectrum of granulocyte adherence reactions. To… Expand
1987
1987
Twenty-six healthy children previously immunized (imm) with the Hib capsular polysaccharide (Hib CP) vaccine at age 19 to 38 mos… Expand
Highly Cited
1985
Highly Cited
1985
Hemophilus influenzae type b (HIB) is the leading cause of bacterial meningitis in the United States. Efforts are under way to… Expand
Highly Cited
1984
Highly Cited
1984
A long-term follow-up of approximately 50,000 children who received the Hemophilus influenzae type b capsular polysaccharide… Expand
1977
1977
An intranasal immunization with a A/PR8/34-isolated NA, protected mice as well as the whole virus and A/Hong Kong/1/68 virus… Expand